Affaitati, Giannapia
Costantini, Raffaele
Tana, Claudio
Lapenna, Domenico
Schiavone, Cosima
Cipollone, Francesco
Giamberardino, Maria Adele
Article History
Received: 24 September 2018
Accepted: 16 October 2018
First Online: 8 November 2018
Ethics approval and consent to participate
: The protocol was approved by the Institutional Review Board of the Department of Medicine and Science of Aging of the G D’Annunzio University of Chieti (Feb. 7, 2018; del. n. 90, Prot. N. 992/27.00 18, Tit III, CI 13). The study being retrospective, no ad-hoc consent was obtained from the patients for this specific protocol. However, informed consent is constantly provided by the patients at first visit at our Headache Center, to carry out all the diagnostic and therapeutic procedures relative to their condition/s; all patients included in the present protocol had signed this consent.
: Not applicable.
: In the past 2 years: GA received personal fees for participation in Conferences from Epitech Group. MAG received research funding for topics unrelated to the present study from Epitech Group, and personal fees for participation in Conferences from IBSA Institute Biochimique, Helsinn Healthcare and Epitech Group. RC, CT, DL, CS and FC have no competing interests in relation to the present study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.